Akèy › Alòpesi Areat › Indiana
Etid klinik pou Alòpesi Areat nan Indiana
8 etid pou Alòpesi Areat ap chèche patisipan nan sit nan Indiana.
Vil nan Indiana
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Oct 2, 2026 · NCT07772492A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- Dawes Fretzin Clinical Research Group, Indianapolis
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Indiana University Health University Hospital /ID# 259827, Indianapolis
Ap rekriteFaz 3
Laj 12 a 63 · Tout sèks · Mizajou Aug 3, 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Ap rekriteFaz 3
Laj 6 a 14 · Tout sèks · Mizajou Apr 28, 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Options Research Group, West Lafayette
Ap rekriteFaz 1/2
Laj 18 a 55 · Tout sèks · Mizajou Mar 4, 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Ds Research - Indiana, Clarksville
- Dawes Fretzin Clinical Research Group Llc., Indianapolis
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Jan 28, 2026 · NCT07133308Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.